Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome

Stroke

Volumn 29, Issue 8, 1998, Pages 1618-1624

  Wardlaw, Joanna M ^a,b   Marshall, Ian ^a   Wild, Jim ^a   Dennis, Martin S ^a   Cannon, Jim ^a   Lewis, Stephanie C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cerebral infarct; Lactate; Magnetic resonance imaging; Middle cerebral artery; N acetylaspartate; Spectroscopy, nuclear magnetic resonance; Stroke; Ultrasound, Doppler, transcranial

Indexed keywords

LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INFARCTION; BRAIN LEVEL; BRAIN METABOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; HUMAN; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0031880193     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.8.1618     Document Type: Article

References (30)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
2. International Stroke Trial Collaborative Group. The International Stroke Trial (TST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
3. Kohno K, Hoehn-Berlage M, Mies G, Back T, Hossmann K-A. Relationship between diffusion-weighted MR images, cerebral blood flow and energy state in experimental brain infarction. Magn Reson Imaging. 1995;13:73-80.
4. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995;26:2219-2221.
5. Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke. 1996;27:599-606.
6. Furlan M, Marchal G, Viader F, Derlon J-M, Baron J-C. Spontaneous neurological recovery after stroke and the fate of the ischaemic penumbra. Ann Neurol. 1996;40:216-226.
7. Prichard JW. The ischemic penumbra in stroke: prospects for analysis by nuclear magnetic resonance spectroscopy. In: Waxman SG, ed. Molecular and Cellular Approaches to the Treatment of Neurological Disease. New York, NY: Raven Press, Publishers; 1993:153-174.
8. Graham GD, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OAC, Shulman RG, Prichard JW. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke. 1992;23:333-340.
9. Gideon P, Henriksen O, Sperling B, Christiansen P, Olsen TS, Jørgensen HS, Arlien-Soøborg P. Early time course of N-acetyl aspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke. 1992;23:1566-1572.
10. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW. Human brain infarction: proton MR spectroscopy. Radiology. 1992;183:711-718.
11. Barker PB, Gillard JH, van Zijl PCM, Soher BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology. 1994;192:723-732.
12. Lanfermann H, Kugel H, Heindel W, Herholz K, Heiss, W-D, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology. 1995;196:203-210.
13. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
14. Saunders DE, Howe FA, Pereira A, Brown MM, Griffiths JR. The use of quantitative MR spectroscopy in the prediction of clinical outcome in MCA infarct patients. Proc Soc Magn Reson Med. 1997;1:40. Abstract.
15. Federico F, Simone IL, Conte C, Lucivero V, Giannini P, Liguori M, Picciola E, Tortorella C. Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke. J Neurol. 1996;243:241-247.
16. Kugel H, Lanfermann H, Pietrzyk U, Herholz K, Heindel W, Heiss WD, Lackner K. NAA decrease in acute and subacute infarcts measured with MRSI correlates with cerebral blood flow measured with PET. Proc Soc Magn Reson Med. 1995;3:1820. Abstract.
17. Graham GD, Kalvach P, Blamire AM, Brass LM, Fayad PB, Prichard JW. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke. 1995;26:225-229.
18. Bamford J, Sandercock PAG, Dennis MS, Burn J, Warlow CP. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-26.
19. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull WHO. 1980;58:113-130.
20. Wardlaw JM, Sellar R. A simple practical classification of cerebral infarct morphology as seen on CT brain scans and its interobserver reliability. Am J Neuroradiol. 1994;15:1933-1939.
21. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci. 1987;508:333-348.
22. Ordidge RJ, Cresshull ID. The correction of transient Bo field shifts following the application of pulsed gradients by phase correction in the time domain. J Magn Reson. 1986;69:151-155.
23. 1H MRS of brain. Magn Reson Imaging 1996; 14:281-292.
24. 1H magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in Signal Processing III. Oxford, England: Clarendon Press; 1994:175-195.
25. 1H NMR spectroscopic imaging. Magn Reson Imaging. 1997;15:1057-1066.
26. Behar K, Rothman DL, Spencer DD, Petroff OAC. Analysis of macro molecule resonances in human brain. Magn Reson Med. 1994;32:294-302.
27. Fazekas F, Kapeller P, Stollberger R, Offenbacher H, Schmidt R, Valetitsch H, Fazekas G, Scheucher R, Flooh E, Lechner H. A follow-up study of cerebral ischemic stroke with 1H-MRS and Tc99-HMPAO SPECT. Cerebrovasc Dis. 1995;5:255. Abstract.
28. Hossman K-A, Schuier FJ. Experimental brain infarcts in cats, II: ischemic brain edema. Stroke. 1980;11:593-601.
29. Gideon P, Henriksen O. In vivo relaxation of N-acetyl aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study. Magn Res Med. 1992; 10:983-988.
30. Bottomley PA. The trouble with spectroscopy papers. J Magn Res Imaging. 1992;2:1-8.